RAC1 and HIV-1 infection: Differentiated MDM were infected for 4 h and treated 1 h prior to or 4 h after HIV-1 infection with CT04 (1 μg/ml) and NSC (75 μM), RhoA or Rac1 GTPase inhibitors, respectively.